Company
Panaxia Labs Israel Ltd
Headquarters: Lod, Israel
Employees: 167
CEO: Dr. Dadi Segal Ph.D.
Market Cap
₪21.8 Million
ILS as of Jan. 1, 2024
US$6.0 Million
Panaxia Labs Israel Ltd Categories
Israel Healthcare Drug Manufacturers—Specialty & GenericIsrael Healthcare Israel Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company offers pharma-grade smokeless cannabis products, such as oral and sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches. Panaxia Pharmaceutical Industries Ltd has strategic partnerships with Ultra Health, Salus Biopharma, MPX Bioceutical Corporation, Rafa, Pharmocann, Seach Medical Cannabis Group, TevaAdir, Better, and Cann10. The company was incorporated in 2016 and is based in Lod, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Panaxia Labs Israel Ltd has the following listings and related stock indices.
Stock: TASE: PNAX wb_incandescent